ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

N4P N4 Pharma Plc

0.525
0.00 (0.00%)
21 Jun 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
N4 Pharma Plc LSE:N4P London Ordinary Share GB00BYW8QM32 ORD 0.4P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.525 0.45 0.60 0.525 0.525 0.53 10,000 08:00:15
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Drug & Proprietary Stores 2k -1.27M -0.0047 -1.11 1.4M
N4 Pharma Plc is listed in the Drug & Proprietary Stores sector of the London Stock Exchange with ticker N4P. The last closing price for N4 Pharma was 0.53p. Over the last year, N4 Pharma shares have traded in a share price range of 0.475p to 2.00p.

N4 Pharma currently has 268,780,349 shares in issue. The market capitalisation of N4 Pharma is £1.40 million. N4 Pharma has a price to earnings ratio (PE ratio) of -1.11.

N4 Pharma Share Discussion Threads

Showing 8576 to 8594 of 8600 messages
Chat Pages: 344  343  342  341  340  339  338  337  336  335  334  333  Older
DateSubjectAuthorDiscuss
19/6/2024
19:18
Why should he add every time. Grow up you two.
johno1977
19/6/2024
08:04
Double post
nobbygnome
19/6/2024
08:04
So he wasn’t confident enough to put in more money at this lowly level despite ramping here
nobbygnome
19/6/2024
07:03
Dilution Dave .. shocker
dplewis1
07/6/2024
15:19
Wow yet another sucker punch for shareholders! Where are those deals which were promised by the resident ramper? He must be rather upset with Nigel….
nobbygnome
07/6/2024
15:16
25% down and diluted to oblivion. Great stuff Nigel.. no wonder he hasn't bought any more shares in ages..lol
dplewis1
07/6/2024
10:34
Best mates ne more
earwacks
07/6/2024
10:21
Oh no Dave .. Nigel's had you over again! How many times??!
dplewis1
23/5/2024
12:38
All resolutions to watch the share price plop under half a penny were passed
dplewis1
23/5/2024
11:58
SRI works with N4 Pharma to target and treat cells in the human body that had been unreachablePaving the way for targeted treatments, the collaboration aims to help realize the full potential of precision healthcare.
pwal
12/5/2024
09:38
next drop 29-39% from current price
vlad the impaler
12/5/2024
09:20
Here is the list of pharma companies participating in the Bio Conference in San Diego in which SRI will be marketing Nuvec to the pharma community around the world between June 3-6.
tankerton
09/5/2024
13:02
How does N4 Pharma plan to navigate the regulatory approval process with regulatory bodies such as the FDA?
The Food and Drug Administration (FDA) has authority to grant orphan drug designation (ODD) to a drug or biological product to prevent, diagnose or treat a rare disease or condition. Being granted ODD can provide various benefits including market exclusivity, tax incentives, eligibility for grants, accelerated approval process and regulatory fee waivers. ODD aims to expedite the development of promising therapies by providing increased support and an accelerated regulatory framework.

fydo
25/4/2024
10:43
I would hope so with the wider exposure to the market this collaboration brings!
jusjusjus
25/4/2024
10:34
Is this collaboration going to help funding?
pwal
25/4/2024
07:57
Turned out to be coming days!
jusjusjus
23/4/2024
11:53
You are right: In the coming weeks as stated later in the report. That would be great news.
pwal
23/4/2024
10:16
Did they say in the coming weeks or in the near future?
pwal
23/4/2024
07:31
Collaborations

The Company is at advanced stages of finalising a collaboration with an independent global leader in R&D based in the US which, on the back of successful initial studies utilising our combined technologies, would lead to a co-marketing agreement to allow both parties to promote the resultant combined technology. We anticipate being able to make a further announcement on this in the coming weeks.

jusjusjus
Chat Pages: 344  343  342  341  340  339  338  337  336  335  334  333  Older

Your Recent History

Delayed Upgrade Clock